Thermo Fisher Scientific Increases Quarterly Dividend and Authorizes New Share Repurchase Program

  Thermo Fisher Scientific Increases Quarterly Dividend and Authorizes New
  Share Repurchase Program

Business Wire

WALTHAM, Mass. -- November 08, 2012

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving
science, today announced that its Board of Directors has authorized an
increase of its quarterly cash dividend from $0.13 to $0.15 per common share,
payable on January 15, 2013, to shareholders of record as of December 17,

The board also authorized the repurchase of an additional $1 billion of shares
of the company’s common stock in the open market or in negotiated
transactions. The new repurchase authorization is effective January 1, 2013.
As of October 1, the company had $350 million remaining under its existing
share repurchase authorization, which expires December 31, 2012.

“Returning capital to our shareholders through stock buybacks continues to be
an important part of our capital deployment strategy,” said Marc N. Casper,
president and chief executive officer of Thermo Fisher Scientific. “We’re also
pleased to announce that we’re increasing our quarterly dividend, based on our
strong performance so far this year and our outlook for the future.”

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving
science. Our mission is to enable our customers to make the world healthier,
cleaner and safer. With revenues of $12 billion, we have approximately 39,000
employees and serve customers within pharmaceutical and biotech companies,
hospitals and clinical diagnostic labs, universities, research institutions
and government agencies, as well as in environmental and process control
industries. We create value for our key stakeholders through three premier
brands, Thermo Scientific, Fisher Scientific and Unity Lab Services, which
offer a unique combination of innovative technologies, convenient purchasing
options and a single solution for laboratory operations management. Our
products and services help our customers solve complex analytical challenges,
improve patient diagnostics and increase laboratory productivity. Visit


Thermo Fisher Scientific Inc.
Media Contact Information:
Ron O’Brien, 781-622-1242
Investor Contact Information:
Ken Apicerno, 781-622-1294
Press spacebar to pause and continue. Press esc to stop.